MANUFACTURING Sustainable development in actionRead more...
Research & Development see our R&D locations around the worldRead more...
PartnershipsAreas of Interest to GaldermaRead more...
You are here »
Dermatology Innovations » Research & Development » Drug discovery
Human Genome Analysis
The whole human genome can be analyzed under differential physio-pathological conditions in a one square cm chip. Genes of interest can be mapped rapidly and this may lead to the identification of proteins and metabolic pathways indicating biological markers and potential new therapeutic targets within a given pathology.
Advanced robotic chain equipment allows the screening of hundreds of thousands of compounds. This helps identify molecules that will work on specific therapeutic targets. These molecules can then be further developed into effective compounds for specific diseases.
State-of-the-art, well-documented, integrated pharmaco-dynamic models in reconstructed skin allow precise early evaluation of the therapeutic potential of future drugs.
New imaging technologies allow qualitative and quantitative assessment of the effects of the potential drugs in tissues and cells. An imaging technology platform helps to find appropriate formulation solutions for future application to humans.
Miniaturized Human Biological Assay
Miniaturized human biological material is used to provide information on early pharmacokinetics such as absorption through the skin or different organs, the metabolic profile, once the compound has been applied topically or administered orally, and early information on safety. The relevance of the data collected at this stage improves attrition rates throughout the process, increasing the efficiency of the overall R&D process.
Discover more about dermatology company Galderma, innovators of therapeutic, aesthetic and corrective dermatology solutions.
Growing a responsible dermatological community
Discover some of the positive initiatives we are involved in across the world
We are committed